J Cancer 2016; 7(2):160-166. doi:10.7150/jca.13243 This issue
Short Research Communication
1. Department of Chemistry, Wellesley College, Wellesley, Massachusetts 02481, USA
2. Department of Biological Sciences, Wellesley College, Wellesley, Massachusetts 02481, USA
Pancreatic cancer is one of the most devastating forms of human cancer. The lack of effective clinical treatments for pancreatic cancer has led to one of the lowest five-year survival rates among all cancers. Recently, our laboratory has developed a novel series of isoprenylated coumarin derivatives that have exhibited anti-pancreatic cancer activity exclusively under nutrient-deprived conditions. In this study, we report the effect of the various cell culture medium components on the preferential cytotoxicity of our lead isoprenylated coumarin compound against the pancreatic adenocarcinoma cell line PANC-1. In particular, our findings show a clear link between observed cytotoxicity and glucose deprivation, suggesting that our compound targets a salvage pathway when glycolysis is no longer an option for cancer cell survival. The cytotoxicity of our lead compound was also examined in vitro against two other pancreatic cancer cell lines, BxPC-3 and Capan-2 under both nutrient-rich and nutrient-deprived conditions.
Keywords: isoprenylated coumarin derivatives, anti-pancreatic cancer